Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Dr. Renu Razdan of leading Indian CRO Max Neeman International, will be attending the World Orphan Drug Congress in April to discuss the latest,...
Max Neeman International announced today that India’s Ministry of Health released an amended draft gazette on medical management with regards to...
The Association of Contract Research Organizations [ACRO] India has appointed Max Neeman's Chief Operating Officer, Dr. Renu Razdan as Vice Chairman. ...
Max Neeman's COO, Dr. Renu Razdan published in BioSpectrum [July 2013]; a prominent industry magazine. As Max Neeman is the leading, local Indian CRO ...
Max Neeman International, a leading Asia-Pacific CRO, has announced successful completion of its first MAXimizer project focused on the Data...
Max Neeman International now has a larger Asia-Pac footprint with new presence and capabilities in neighboring countries of Bangladesh, Sri Lanka and ...
Max Neeman International announced today that they have provided Data Management services to over 60 countries and have completed 250 Medical Writing ...
A dedicated and experienced Max Neeman team has been set-up to conduct Biosimilar studies for evaluation and efficacy of products. The company...
Max Healthcare, India's first comprehensive provider of standardized, seamless and world-class healthcare services, today announced organizational...
Max Neeman International is the only CRO in India to manage hemophilia trials according to the Clinical Trials Registry-India (CTRI). Of the total...
Max Neeman announces the grant of ISO 14155:2011 certificate; the only Indian CRO and one of only a few global CROs to be certified for design,...
Leading India-based CRO, Max Neeman International, creates and launches customized Project Management Software (PMS) to meet unique study needs and...
Max Neeman International, leading Indian CRO, is part of the prestigious Max Group whose sister-company, Max Healthcare recently had one of 12...
The Drug Controller General of India (DCGI) has formed new Regulatory and ICH GCP guidelines. These guidelines include: recommendations regarding...
Max Neeman meets enrollment and timeline of 15,000 for a large, Phase IV metabolic disorder trial across 1200 sites throughout India. As a leading...
Max Neeman International has established a team of experts specialized in carrying out rare disease trials in response to sponsor demand. The team...
India's premier CRO, Max Neeman, participated in the 59th annual Neurological Society of India & Congress of Neurological Surgeons (NEUROCON) held in ...
Max Neeman International, India's premier CRO, has quadrupled the amount of clinical trials awarded since 2007 and reached the milestone of over 200...
Max Neeman announces the grant of ISO 27001:2005 certificate; one of only a few Indian CROs to be certified for Information Security. (Logo:...
Max Neeman International announced today that Dr. Renu Razdan has been featured in the November issue of BioSpectrum India as a prominent female...
India has evolved into a preferred destination for conducting clinical trials in large part because the Indian Regulatory bodies have created an...
A global pharmaceutical company has initiated a prospective trial to evaluate the impact of insulin guidelines developed by the Indian National...
Max Neeman International, a leading Indian CRO, announces the expansion of therapeutic focused device clinical trial services in India. Max Neeman...
Max Neeman International, India's premier CRO, has expanded its team of medical writers in response to the growing demand for medical writing...
Max Neeman International, India's premier CRO, created a niche in Data Management services and has extended the platform to provide expert CDISC...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.